![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.395 | -8.31% | 4.36 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:09:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/5/2020 22:19 | I'd like to believe you amaretto but forgive me if I don't. The furlough scheme extended to October suggests to me mass redundancy in autumn. Just at the time when flu season starts and they'll try to create fear of a resurgence. The stock market and housing market are simply not going to shrug this off. It's unprecedented and completely disproportionately bonkers response to this. My personal ace is TXP. No ramp intended but it's well worth adding to your watch list imo. | ![]() spawny100 | |
15/5/2020 22:12 | FTSE 55-64 .. repeat | ![]() amaretto1 | |
15/5/2020 22:06 | Risky strategy | ![]() dave444 | |
15/5/2020 21:52 | It is. Temporary situation whilst I find a slightly less crazy country to reside in. | ![]() spawny100 | |
15/5/2020 21:16 | Yikes. motor home. That really is end of the world stuff! lol | ![]() waterloo01 | |
15/5/2020 20:27 | But the world economy has been wrecked to such a degree that the recession will be deep and long. The virus will carry on having a big effect on certain parts of the economy for many months to come. There is no way that is priced in currently so a lot more downside to come IMHO once it becomes obvious how bad the damage to the economy really is! | ![]() nobbygnome | |
15/5/2020 19:18 | Just buy Tally Money. Can liquidise your position and have it back in fiat within two hours if needed. | ![]() talk2dubya | |
15/5/2020 18:55 | Gold will. Look at GGP. languished for ages. | ![]() dealer55 | |
15/5/2020 18:54 | Agree...maybe 1 or 2 years !Buying time That's when gold will sky rocket | ![]() amaretto1 | |
15/5/2020 18:30 | And been handed a shed load of dollars by the Fed to buy up the corporate debt market. Oil is up and ten year yield stabilised. Looks bullish, but only storing up trouble for the future. | ![]() talk2dubya | |
15/5/2020 18:23 | They won't let it drop...Not till we are Corona free + back to normalise No matter what it takes.. Hedge funds have had orders ! FACT | ![]() amaretto1 | |
15/5/2020 18:21 | Unlike the credit crunch the banks have cash and the government’s aren’t spending cash to buy banks. So naively I feel the drop will be more severe than 2008 but bounce back could be good. We have convinced the globe 2020 was a recession year anyway. Stay sharp. GLA | ![]() dealer55 | |
15/5/2020 17:36 | Powell joins the battle over fiscal spending After the House of Representatives released a proposed $3 trillion relief bill on Tuesday, Fed chair Jerome Powell weighed in, backing calls for Congress to do more to battle the economic impact of the coronavirus pandemic. Why it matters: Expectations for the pandemic-fueled recession are morphing from a short-term downturn to a potentially yearslong slog and economists are urging policymakers to adjust government spending accordingly. • Powell's comments Wednesday made him the latest and perhaps most influential voice in a chorus advocating more fiscal spending. Driving the news: In pre-written remarks, Powell detailed the harms of "deeper and longer" recessions, warning that "the recovery may take some time to gather momentum and time can turn liquidity problems into solvency problems." • "Additional fiscal support could be costly, but worth it if it helps avoid long-term economic damage and leaves us with a stronger recovery," Powell said during a webcast with the Peterson Institute for International Economics. Between the lines: "Fed officials are unanimous on this — they are all in on, 'Congress has to do more,'" Claudia Sahm, a former top Fed economist and now director of macroeconomic policy at the Washington Center for Equitable Growth, said during a separate online event. What's happening: Recent economic studies and business developments are starting to back Powell's worries that the Fed and Congress will need to provide assistance to the U.S. economy for some time. • In addition to the record high unemployment rate, thousands of business closures and wave of bankruptcies, new academic research estimates that 42% of recent layoffs will result in permanent job loss. Yes, but: "Right now in the White House, we’re in wait and see mode," White House economic adviser Kevin Hassett said during a briefing with the Brookings Institution Tuesday. | ![]() bmnsa | |
15/5/2020 17:27 | The US is actually bouncing back at the moment | ![]() judijudi | |
15/5/2020 17:07 | US market watchers- Terrible figures out in the US Retail sales -17.2% far worse than forecasts of -8.6% Manufacturing production -13.7% as against forecasts of -13% US markets falling again. - - - - - - - - - - - - Hang on to those SNG golden tickets The US may well want a few as the weeks pass by and covid brings a 2nd wave of distress. | ![]() bmnsa | |
15/5/2020 17:01 | This is very exciting when read in conjunction with the paper I shared yesterday. If Interferon-a2b clears it 7 days faster, then based on the below IFNβ1a has the potential to be even faster... Type 1 interferons as a potential treatment against COVID-19 "It was repeatedly shown that IFNβ is a more potent inhibitor of coronaviruses than IFNα (Scagnolari et al., 2004; Stockman et al., 2006): depending on the studies, IFNβ1b or IFNβ1a were the most potent IFN-I subtype in the inhibition of SARS-CoV (Hensley et al., 2004) and MERS-CoV (Chan et al., 2013; Dong et al., 2020; Hart et al., 2014). Consequently, IFNβ1 appears to be most relevant interferon to treat coronavirus infections." | ![]() 74tom | |
15/5/2020 16:48 | Results read a lot better than the Gilead drug, and that's ignoring the Gilead adverse events. | ![]() waterloo01 | |
15/5/2020 16:44 | It is the same data as before but this is the final peer reviewed paper I think. It does more or less translate to the SNG trial although they are using a slightly higher overall dose of interferon beta. However, they are not using an optimised nebulisation device so that is probably not an issue. Overall the data is very encouraging as I said at the time the data first appeared. It is by far and away the most encouraging data for SNG001! | ![]() nobbygnome | |
15/5/2020 16:43 | I think its new, the Canadian company said it was being published today and it is dated today. There was a trial out of Hong Kong last week which was an injectable version, this is nebulised. | ![]() pdt | |
15/5/2020 16:43 | Mirror article posted 15th May 2020Fresh from the print! | itshenderz | |
15/5/2020 16:42 | Looks new to me. | ![]() waterloo01 | |
15/5/2020 16:41 | Beer time. I think we can expect a steady rise to results now with spikes on updates. Have a good weekend all. | ![]() dovey21 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions